ES2541683T3 - Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6 - Google Patents

Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6 Download PDF

Info

Publication number
ES2541683T3
ES2541683T3 ES05707586.3T ES05707586T ES2541683T3 ES 2541683 T3 ES2541683 T3 ES 2541683T3 ES 05707586 T ES05707586 T ES 05707586T ES 2541683 T3 ES2541683 T3 ES 2541683T3
Authority
ES
Spain
Prior art keywords
interleukin
rheumatoid arthritis
based methods
methods
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05707586.3T
Other languages
English (en)
Spanish (es)
Inventor
Norbert Wild
Johann Karl
Veit Peter Grunert
Werner Zolg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2541683T3 publication Critical patent/ES2541683T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ES05707586.3T 2004-02-27 2005-02-23 Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6 Active ES2541683T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04004536 2004-02-27
EP04004536 2004-02-27
EP04008586 2004-04-08
EP04008586 2004-04-08
PCT/EP2005/001862 WO2005085859A1 (fr) 2004-02-27 2005-02-23 Methode permettant d'evaluer la polyarthrite rhumatoide en mesurant le taux de facteur rhumatoide et d'interleukine 6

Publications (1)

Publication Number Publication Date
ES2541683T3 true ES2541683T3 (es) 2015-07-23

Family

ID=34921302

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05707586.3T Active ES2541683T3 (es) 2004-02-27 2005-02-23 Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6

Country Status (6)

Country Link
US (1) US20070072237A1 (fr)
EP (1) EP1721163B1 (fr)
JP (1) JP4610605B2 (fr)
CA (1) CA2552425C (fr)
ES (1) ES2541683T3 (fr)
WO (1) WO2005085859A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408891B2 (en) 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
KR101314461B1 (ko) 2004-05-12 2013-10-07 더 브리검 앤드 우먼즈 하스피털, 인크. 감염 치료를 위한 겔솔린의 용도
HUE056086T2 (hu) 2006-03-15 2022-01-28 Brigham & Womens Hospital Inc Gelszolin alkalmazása gyulladásos betegségek diagnosztizálására és kezelésére
JP2010506147A (ja) * 2006-09-29 2010-02-25 エフ．ホフマン−ラ ロシュ アーゲー 関節リウマチを有する患者のための疾患進行のリスク評価
HUE032875T2 (en) 2008-01-25 2017-11-28 Massachusetts Gen Hospital Diagnostic and therapeutic applications of gelsolin in renal failure
WO2010075249A2 (fr) 2008-12-22 2010-07-01 Genentech, Inc. Méthode de traitement de la polyarthrite rhumatoïde avec des antagonistes de cellules b
JP5786020B2 (ja) * 2010-04-16 2015-09-30 アボットジャパン株式会社 関節リウマチを診断する方法および試薬
US20140142861A1 (en) * 2010-11-06 2014-05-22 Oklahoma Medical Research Foundation Biomarkers For Predicting Progressive Joint Damage
ES2634458T3 (es) * 2011-05-19 2017-09-27 Mochida Pharmaceutical Co., Ltd. Diagnóstico de enfermedad infecciosa del tracto respiratorio usando muestras de sangre
WO2018021624A1 (fr) * 2016-07-29 2018-02-01 가톨릭대학교 산학협력단 Biomarqueurs pour le diagnostic de la polyarthrite rhumatoïde
WO2018215528A1 (fr) * 2017-05-24 2018-11-29 Koninklijke Philips N.V. Diagnostic d'une parodontite légère ou avancée basée sur il-1 bêta et mmp-9 salivaires
WO2023023338A1 (fr) * 2021-08-19 2023-02-23 Navidea Biopharmaceuticals, Inc. Compositions et méthodes pour le traitement de la polyarthrite rhumatoïde
CN116148466B (zh) * 2023-04-23 2023-11-21 北京大学人民医院 用于类风湿关节炎诊断的多血清标志物组合

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012333A1 (fr) * 1990-02-07 1991-08-22 Kanebo, Ltd. Anticorps monoclonal antiprocollagenase et essai de depistage de procollagenase au moyen de cet anticorps
JPH085920B2 (ja) * 1991-01-21 1996-01-24 富士薬品工業株式会社 抗ヒトストロムライシンモノクローナル抗体及び酵素免疫測定法
JP2673929B2 (ja) * 1993-04-12 1997-11-05 富士薬品工業株式会社 ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用
WO2001022085A1 (fr) * 1999-09-17 2001-03-29 Mochida Pharmaceutical Co., Ltd. Procede de mesure fractionnel de proteine de cd14 soluble
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
CN100352844C (zh) * 2001-09-25 2007-12-05 财团法人化学及血清疗法研究所 重组抗骨桥蛋白抗体及其用途
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis

Also Published As

Publication number Publication date
EP1721163B1 (fr) 2015-04-29
JP2007524101A (ja) 2007-08-23
US20070072237A1 (en) 2007-03-29
EP1721163A1 (fr) 2006-11-15
CA2552425A1 (fr) 2005-09-15
CA2552425C (fr) 2018-02-06
WO2005085859A1 (fr) 2005-09-15
JP4610605B2 (ja) 2011-01-12

Similar Documents

Publication Publication Date Title
ES2541683T3 (es) Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6
Procopio et al. Forensic proteomics for the evaluation of the post-mortem decay in bones
Stayton et al. Molecular recognition at the protein-hydroxyapatite interface
Buckley et al. Proteome degradation in ancient bone: diagenesis and phylogenetic potential
Karsdal et al. Extracellular matrix remodeling: the common denominator in connective tissue diseases possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure
Hooi et al. Racemisation and human cataract. d-Ser, d-Asp/Asn and d-Thr are higher in the lifelong proteins of cataract lenses than in age-matched normal lenses
Decker et al. Genesis and morphogenesis of limb synovial joints and articular cartilage
Herrera et al. Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis
Bateman et al. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta
Geiger et al. Molecular architecture and function of matrix adhesions
DE69226548T3 (de) Verfahren zum Nachweis des Abbaus von Typ-I-Kollagen
Merritt et al. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes
Huebner et al. Alpha C‐telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis
Tam et al. DIPPER, a spatiotemporal proteomics atlas of human intervertebral discs for exploring ageing and degeneration dynamics
CA2110263A1 (fr) Detection de la collagenolyse in vivo
Coupes et al. TRANSFORMING GROWTH FACTOR β1 IN RENAL ALLOGRAFT RECIPIENTS1
Genovese et al. Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers
Tabassi et al. Monitoring cartilage turnover
Gudmann et al. Type II collagen
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
James et al. Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents
Vos et al. In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage
Adepu et al. Biglycan neo-epitope (BGN262), a novel biomarker for screening early changes in equine osteoarthritic subchondral bone
Mahmoodian et al. Changes in mechanics and composition of human talar cartilage anlagen during fetal development
CN101680901A (zh) Ix型胶原破坏的诊断